Praxis Precision Medicines, Inc. Common Stock (PRAX) Stock Price, Quote & AI Analysis

Live PRAX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Praxis Precision Medicines, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Praxis Precision Medicines, Inc. Common Stock (PRAX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

PRAX
Praxis Precision Medicines, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$8,596,837,408.64
52W Range
$26.70 - $326.91
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 26, 2026 Q4
After Hours
EPS Estimate: $-3.1564
Revenue Estimate: $47,073.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Praxis Precision Medicines, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Praxis Precision Medicines, Inc. Common Stock Overview

Company information

Company Overview

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Company Details
Market Cap
$8.62B
Shares Outstanding
27,407,100
Weighted Shares Outstanding
27,738,892
CEO
Marcio Souza
Address
99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
Employees
10,998
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Praxis Precision Medicines, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...